Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

May 15, 2019

SELL
$3.1 - $4.8 $792,418 - $1.23 Million
-255,619 Closed
0 $0
Q4 2018

Feb 14, 2019

SELL
$2.86 - $8.0 $1.3 Million - $3.64 Million
-455,618 Reduced 64.06%
255,619 $920,000
Q2 2018

Aug 14, 2018

BUY
$5.48 - $10.24 $3.9 Million - $7.28 Million
711,237 New
711,237 $6.33 Million

Others Institutions Holding ASLN

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0

About ASLAN Pharmaceuticals Ltd


  • Ticker ASLN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,744,704
  • Market Cap $41.8M
  • Description
  • ASLAN Pharmaceuticals Limited, a clinical-stage immunology focused biopharmaceutical company, engages in developing various treatments to transform the lives of patients. The company's clinical portfolio comprises ASLAN004, a monoclonal therapy that is being developed in atopic dermatitis and other immunology indications; and ASLAN003, a small-m...
More about ASLN
Track This Portfolio

Track Prince Street Capital Management LLC Portfolio

Follow Prince Street Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prince Street Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prince Street Capital Management LLC with notifications on news.